Hepatitis G virus: a suitable marker of in vivo efficacy for pathogen inactivation.
Being an orphan virus despite a large number of investigations, hepatitis G virus is a blood-borne agent for which screening is not required in blood donations. The in vivo efficacy of pathogen inactivation methods could be assessed by the absence of hepatitis G virus markers after transfusion of pathogen-inactivated blood products, in recipients susceptible to infection before the transfusion.
Lefrère
J-J
JJ
Department of Blood-Transmissible Agents, National Institute of Blood Transfusion, Paris, France. jeanjacqueslefrere@orange.fr
Laperche
S
S
Roudot-Thoraval
F
F
D015415:Biomarkers / Q000097:blood; D001803:Blood Transfusion / Q000592:standards; D029407:GB virus C / Q000302:isolation & purification*; D006801:Humans; D011786:Quality Control; D065227:Transfusion Reaction; D038301:Virus Inactivation
D015415:Biomarkers